首页 | 本学科首页   官方微博 | 高级检索  
     

恶性疟合并溶血尿毒综合征的诊疗探讨
引用本文:王爱彬,田地,蒋荣猛,李辉,王琳,倪亮,徐艳利,宋蕊,卢联合,陈志海. 恶性疟合并溶血尿毒综合征的诊疗探讨[J]. 中华实验和临床感染病杂志(电子版), 2016, 10(1): 57-61. DOI: 10.3877/cma.j.issn.1674-1358.2016.01.013
作者姓名:王爱彬  田地  蒋荣猛  李辉  王琳  倪亮  徐艳利  宋蕊  卢联合  陈志海
作者单位:1. 100015 北京,首都医科大学附属北京地坛医院感染性疾病诊疗中心、感染病科国家临床重点专科
摘    要:
目的探讨恶性疟引起的溶血尿毒综合征(HUS)的诊断及治疗要点。 方法对本院2008至2014年13例恶性疟引起的溶血尿毒综合征患者的临床特点、辅助检查及治疗情况进行回顾性分析。 结果入组患者中男性12例,女性1例,年龄22~60岁,均符合恶性疟疾合并溶血尿毒综合征的诊断。其中10例合并脑型疟,1例合并消化道出血,2例出现呼吸循环衰竭。经抗疟原虫治疗、激素治疗、补液对症治疗以及呼吸机、血液透析滤过等,入组的13例患者中1例死亡,1例自动出院,11例治愈出院,其中5例因急性肾功能衰竭行血液透析滤过治疗肾功能恢复,随访11例治愈患者均未出现慢性肾功能损害,2例病例出现再燃。 结论疟疾的早期诊断及治疗,对控制溶血及阻止脏器损害具有重要作用;大剂量长疗程使用蒿甲醚可增强抗疟原虫效果,早期应用激素可有效阻止溶血,减轻肾脏损害,对严重溶血、急性肾功能衰竭病例应及时采取血液透析滤过治疗,以降低病死率。

关 键 词:恶性疟  溶血尿毒综合征  诊断  治疗  
收稿时间:2014-04-27

Diagnosis and treatment of hemolytic uremic syndrome in cases with Falciparum malaria
Aibin Wang,Di Tian,Rongmeng Jiang,Hui Li,Lin Wang,Liang Ni,Yanli Xu,Rui Song,Lianhe Lu,Zhihai Chen. Diagnosis and treatment of hemolytic uremic syndrome in cases with Falciparum malaria[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Version), 2016, 10(1): 57-61. DOI: 10.3877/cma.j.issn.1674-1358.2016.01.013
Authors:Aibin Wang  Di Tian  Rongmeng Jiang  Hui Li  Lin Wang  Liang Ni  Yanli Xu  Rui Song  Lianhe Lu  Zhihai Chen
Affiliation:1. The Center of Infectious Diseases (National Clinical Key Specialty for Infection Diseases), Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
Abstract:
ObjectiveTo explore the clinical features and therapeutic strategy for hemolytic uremic syndrome (HUS) associated with falciparum malaria. MethodsThe medical records of 13 patients with HUS who were admitted to Beijing Ditan Hospital, Capital Medical University from 2008 to 2014 were reviewed, retrospectively. The clinical features, auxiliary examination results and therapeutic strategy were assessed, respectively. ResultsAmong the 13 cases, 12 cases were male and 1 was female; ages of the 13 patients were ranged from 22 to 60 years old. Every patient conformed to the diagnosis of HUS associated with falciparum malaria. There were 10 patients developed cerebral malaria, one case was secondary to gastrointestinal bleeding and 2 patients had respiratory and circulatory failure. After treatments of anti-malaria, hormone therapy, ventilator-assisted and continuous venovenous hemodiafiltration (CVVHDF), etc, one patient died, one patient was discharged by his own accord, and 11 patients were cured with no chronic renal damage. Five patients with acute renal failure were recovered by CVVHDF. During the follow up visiting, two of them recrudesced. ConclusionsEarly diagnosis and treatment of malaria play important roles in hemolysis and organ damage. High-dose, long period of treatment with the artemether can strengthen resistance to malaria. Early application of hormone could prevent hemolysis and alleviate kidney damage effectively. In order to reduce mortality, patients who have severe hemolysis or acute renal failure should be treated with hemodiafiltration therapy in time.
Keywords:Falciparum malaria  Hemolytic uremic syndrome  Diagnosis  Treatment  
本文献已被 CNKI 等数据库收录!
点击此处可从《中华实验和临床感染病杂志(电子版)》浏览原始摘要信息
点击此处可从《中华实验和临床感染病杂志(电子版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号